The page you are looking for does not exist on our servers or has been moved. Please contact the administrator of the referring page and ask them to remove or update their link. Please return to the home page.

BenzaClin® Topical Gel is indicated for the treatment of acne.

IMPORTANT SAFETY INFORMATION

BenzaClin® is well tolerated. Adverse events reported in clinical trials include dry skin (12%), application site reaction (3%), pruritus (2%), peeling (2%), erythema (1%), and sunburn (1%). BenzaClin® Topical gel is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. It is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis. Diarrhea, bloody diarrhea, and pseudomembranous colitis have been reported with topical clindamycin. Discontinuation is recommended if significant diarrhea develops.

For more information, please see Full Prescribing Information for BenzaClin®.

Your privacy
Dermik Laboratories respects your interest in keeping your personal health information private. The information you provide below will be used only for the purpose of sending an email message to the recipient and will not be saved. For more information, see our Privacy Policy.

Your name:

Your email address:

Recipient's email address:

Processing...

Thank you!
Your email has been sent.